Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 7/2009

01-07-2009 | Retinal Disorders

An epidemiological approach for the estimation of disease onset in Central Europe in central and peripheral monogenic retinal dystrophies

Authors: Elena Prokofyeva, Robert Wilke, Gunnar Lotz, Eric Troeger, Torsten Strasser, Eberhart Zrenner

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 7/2009

Login to get access

Abstract

Purpose

To study clinical patterns of disease onset in monogenic retinal dystrophies (MRD), using an epidemiological approach.

Methods

Records of patients with MRD, seen at the University Eye Hospital Tuebingen from 1994 to 1999, were selected from a database and retrospectively reviewed. For analysis, patients were divided into 2 groups by predominant part of visual field (VF) involvement: group 1 (predominantly central involvement) included Stargardt disease (ST), macular dystrophy (MD), and central areolar choroidal dystrophy (CACD), and group 2 (predominantly peripheral involvement) included Bardet–Biedl syndrome (BBD), Usher syndrome (USH) I and II, and choroideremia (CHD). Age, sex, age of first diagnosis, age of visual acuity (VA) decrease and VF emergence, night blindness and photophobia onset, types of VF defects and age of its onset, color discrimination defects and best corrected VA were analyzed.

Results

Records of 259 patients were studied. Men were more prevalent than women. Mean age of the patients was 47.2 (SD = 15.6) years old. Forty-five patients in the first group and 40 in the second were first diagnosed between 21 and 30 years of age. Ninety-four patients in the first group had VA decrease before 30 years of age; in the second group, 68 patients had VA decrease onset between 21 and 40 years of age. Forty-four patients in the first group noticed VF at an age between 21 and 30 years, and 74 patients between 11 and 30 years in the second group. Central scotoma was typical for the first group, and was detected in 115 patients. Concentric constriction was typical for the second group, and was found in 81 patients. Half of patients in both groups preserved best-corrected VA in the better eye at a level of 20/40 or better; 7% in the first group and 6% in the second group were registered as legally blind according to WHO criteria, having VA <1/50 or VF <5°. Diagnosis frequency was USH I and II—34%, ST—31%, MD—18%, CHD—14%, BBD—5%.

Conclusions

An epidemiological approach to the estimation of the disease onset of various subtypes of monogenic retinal degenerations will be useful for detection of disease duration, its prognosis, rehabilitation and the researching of future treatment possibilities.
Literature
1.
go back to reference Ayuso C, Garcia-Sandoval B, Najera C, Valverde C, Carballo M, Antino G (1995) Retinitis pigmentosa in Spain. The Spanish multicentric and multidisciplinary group for research into retinitis pigmentosa. Clin Genet 48(3):120–122PubMedCrossRef Ayuso C, Garcia-Sandoval B, Najera C, Valverde C, Carballo M, Antino G (1995) Retinitis pigmentosa in Spain. The Spanish multicentric and multidisciplinary group for research into retinitis pigmentosa. Clin Genet 48(3):120–122PubMedCrossRef
4.
go back to reference Cideciyan AV, Aleman TS, Boye SL, Schwartz SB et al (2008) Human gene therapy for RPE65 isomerase dificiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA 105(39):15112–15117. doi:10.1073/pnas.0807027105 PubMedCrossRef Cideciyan AV, Aleman TS, Boye SL, Schwartz SB et al (2008) Human gene therapy for RPE65 isomerase dificiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA 105(39):15112–15117. doi:10.​1073/​pnas.​0807027105 PubMedCrossRef
5.
go back to reference Grøndahl J (1987) Estimation of prognosis and prevalence of retinitis pigmentosa and Usher syndrome in Norway. Clin Genet 31(4):255–264PubMed Grøndahl J (1987) Estimation of prognosis and prevalence of retinitis pigmentosa and Usher syndrome in Norway. Clin Genet 31(4):255–264PubMed
7.
9.
go back to reference Krumpatszky HG (1996) Epidemiology of blindness and eye disease. Ophthalmologica 210:1–84CrossRef Krumpatszky HG (1996) Epidemiology of blindness and eye disease. Ophthalmologica 210:1–84CrossRef
10.
12.
go back to reference Marmor MF (1980) Visual loss in retinitis pigmentosa. Am J Ophthalmol 89(5):692–698PubMed Marmor MF (1980) Visual loss in retinitis pigmentosa. Am J Ophthalmol 89(5):692–698PubMed
13.
go back to reference McNeil JM (1991) Americans with disabilities: 1991–92. U.S. Census Bureau McNeil JM (1991) Americans with disabilities: 1991–92. U.S. Census Bureau
15.
go back to reference Puech B, Kostrubiec B, Hache JC, Francois P (1991) Epidemiology and prevalence of hereditary retinal dystrophies in the Northern France. J Fr Ophtalmol 14(3):153–164PubMed Puech B, Kostrubiec B, Hache JC, Francois P (1991) Epidemiology and prevalence of hereditary retinal dystrophies in the Northern France. J Fr Ophtalmol 14(3):153–164PubMed
20.
go back to reference Zrenner E (2007) Subretinal implants for the restitution of vision in blind patients. ARVO Annual Meeting, Fort Lauderdale, FL, USA Zrenner E (2007) Subretinal implants for the restitution of vision in blind patients. ARVO Annual Meeting, Fort Lauderdale, FL, USA
Metadata
Title
An epidemiological approach for the estimation of disease onset in Central Europe in central and peripheral monogenic retinal dystrophies
Authors
Elena Prokofyeva
Robert Wilke
Gunnar Lotz
Eric Troeger
Torsten Strasser
Eberhart Zrenner
Publication date
01-07-2009
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 7/2009
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-009-1059-9

Other articles of this Issue 7/2009

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2009 Go to the issue